Authors: Xu, YC Johnson, KW Phebus, LA Cohen, M Nelson, DL Schenck, K Walker, CD Fritz, JE Kaldor, SW LeTourneau, ME Murff, RE Zgombick, JM Calligaro, DO Audia, JE Schaus, JM

Citation: Yc. Xu et al., N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy, J MED CHEM, 44(24), 2001, pp. 4031-4034

Authors: Rasmussen, K Calligaro, DO Czachura, JF Dreshfield-Ahmad, LJ Evans, DC Hemrick-Luecke, SK Kallman, MJ Kendrick, WT Leander, JD Nelson, DL Overshiner, CD Wainscott, DB Wolff, MC Wong, DT Branchek, TA Zgombick, JM Xu, YC

Citation: K. Rasmussen et al., The novel 5-hydroxytryptamine(1A) antagonist LY426965: effects on nicotinewithdrawal and interactions with fluoxetine, J PHARM EXP, 294(2), 2000, pp. 688-700

Authors: Xu, YC Schaus, JM Walker, C Krushinski, J Adham, N Zgombick, JM Liang, SX Kohlman, DT Audia, JE

Citation: Yc. Xu et al., N-methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist, J MED CHEM, 42(3), 1999, pp. 526-531

Authors: Chen, JJ Vasko, MR Wu, XP Staeva, TP Baez, M Zgombick, JM Nelson, DL

Citation: Jj. Chen et al., Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture, J PHARM EXP, 287(3), 1998, pp. 1119-1127